Trial intelligence / Profile preview

Exparel in Total Knee Arthroplasty

NCT03541265Completed

Sponsor
BronxCare Health System
Start
May 2016
Primary completion
Jun 2017
Modality
Small Molecules
01

Overview

Randomised, open-label trial of bupivacaine in postoperative pain, sponsored by BronxCare Health System. Primary endpoint: Mean pain scores at 3 days. Started May 2016; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03541265.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03541265.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call